The Riley Hospital for Children at Indiana University Health is a nationally ranked freestanding 354-bed, pediatric acute care children's hospital in Indianapolis, Indiana, United States. It is affiliated with the Indiana University School of Medicine.

There are 354 beds in James Whitcomb Riley Hospital for Children.

During the past decade, James Whitcomb Riley Hospital for Children conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "James Whitcomb Riley Hospital for Children" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "Indiana University" with 2 trials sponsored, "MedImmune LLC" with 2 trials sponsored, "Boston Children's Hospital" with 1 trials sponsored and "Connecticut Children's Medical Center" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "James Whitcomb Riley Hospital for Children" #1 collaborator was "Children's Oncology Group" with 2 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Centocor, Inc." with 1 trials as a collaborator, "Children's Hospital Medical Center, Cincinnati" with 1 trials as a collaborator and "EsPhALL" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "James Whitcomb Riley Hospital for Children" are "Cystic Fibrosis" (3 trials), "Anemia" (1 trials), "B-Cell Acute Lymphoblastic Leukemia" (1 trials), "Congenital Heart Disease" (1 trials) and "Deep Vein Thrombosis" (1 trials). Many other conditions were trialed in "James Whitcomb Riley Hospital for Children" in a lesser frequency.

Most popular intervention types in "James Whitcomb Riley Hospital for Children" are "Drug" (6 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "AZLI 75 mg three times daily (TID)" (1 trials), "CTL019" (1 trials), "Dasatinib" (1 trials), "Denufosol Tetrasodium (INS37217) Inhalation Solution" (1 trials) and "Ipilimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "James Whitcomb Riley Hospital for Children" are 14 trials for "All" genders.

Currently, there are NaN active trials in "James Whitcomb Riley Hospital for Children". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in James Whitcomb Riley Hospital for Children, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in James Whitcomb Riley Hospital for Children, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".